Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06277154Phase 2Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
AngiosarcomaDesmoplastic Small Round Cell TumorEndometrial Stromal Sarcoma+8 more
PrincipalinvestigatorStart date: 2024-02-21

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xing Zhang

Sun Yat-Sen University Cancer Center

Very Similar
2 trials

Shared therapeutic areas:

HemangiosarcomaDesmoplastic Small Round Cell TumorSarcoma, Endometrial Stromal+8 more

Worked with same sponsors:

HRYZ Biotech Co.Sun Yat-Sen University Cancer Center
Collaborated on 1 trial
Similarity Score114%

William Tap, MD

Memorial Sloan Kettering Cancer Center

Related
5 trials

Shared therapeutic areas:

LeiomyosarcomaMalignant Peripheral Nerve Sheath TumorsHemangiosarcoma+1 more
Similarity Score11%

Alberto Chiappori, M.D.

H. Lee Moffitt Cancer Center and Research Institute

Related
5 trials

Shared therapeutic areas:

FibrosarcomaLeiomyosarcomaLiposarcoma
Similarity Score8%

Jordan Milner, MD

University of Florida

Related
4 trials

Shared therapeutic areas:

Desmoplastic Small Round Cell TumorSarcoma, EpithelioidSarcoma, Synovial
Similarity Score8%

Sandra D'Angelo, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

LeiomyosarcomaUndifferentiated Pleomorphic Sarcoma
Similarity Score5%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

LiposarcomaSarcoma, Synovial
Similarity Score5%

Crystal L Mackall, M.D.

National Cancer Institute (NCI)

Related
5 trials

Shared therapeutic areas:

Malignant Peripheral Nerve Sheath TumorsSarcoma, Synovial
Similarity Score5%

Vincent Chung, MD

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

LeiomyosarcomaSarcoma, Synovial
Similarity Score5%

Vivek Subbiah, MD

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

LiposarcomaSarcoma, Synovial
Similarity Score5%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

LeiomyosarcomaSarcoma, Synovial
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06277154Phase 2PrincipalInvestigator

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

AngiosarcomaDesmoplastic Small Round Cell TumorEndometrial Stromal Sarcoma+8 more
Recruiting

All 1 trials loaded